Biomarker Testing in Lung Cancer Treatment, Monitoring Progression & Managing Resistance (part 2)
Impossible d'ajouter des articles
Échec de l’élimination de la liste d'envies.
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
Biomarker Testing in Lung Cancer Treatment, Monitoring Progression & Managing Resistance (part 2)
-
Lu par :
-
De :
À propos de ce contenu audio
In Part 2 of this series, Leah Phillips continues her conversation with Dr. Ben Creelan and Dr. Jhanelle Gray from Moffitt Cancer Center. This episode transitions from the basics of diagnosis to the practical application of biomarker testing throughout the entire patient journey.
Our experts discuss how molecular profiles determine the choice between oral targeted therapies (TKIs) and traditional chemotherapy, and the impact of these options on patient quality of life.
00:00 Introduction to Biomarker Testing in Lung Cancer
02:13 The Role of Biomarkers in Treatment Decisions
05:07 Understanding Repeat Biomarker Testing
07:20 Managing Resistance Mutations and Treatment Adjustments
10:10 The Importance of Clinical Trials
12:38 Advancements in Targeted Therapies
15:22 The Future of Biomarker Testing and Patient Empowerment
This episode is proudly sponsored by Nuvation Bio
